These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 15583079

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
    Bloomfield DM, Steinman RC, Namerow PB, Parides M, Davidenko J, Kaufman ES, Shinn T, Curtis A, Fontaine J, Holmes D, Russo A, Tang C, Bigger JT.
    Circulation; 2004 Oct 05; 110(14):1885-9. PubMed ID: 15451804
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Long-term incidence of malignant ventricular arrhythmia and shock therapy in patients with primary defibrillator implantation does not differ from event rates in patients treated for survived cardiac arrest.
    Backenköhler U, Erdogan A, Steen-Mueller MK, Kuhlmann C, Most A, Schaefer C, Stertmann W, Waas W, Tillmanns H, Waldecker B.
    J Cardiovasc Electrophysiol; 2005 May 05; 16(5):478-82. PubMed ID: 15877617
    [Abstract] [Full Text] [Related]

  • 26. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH, Lin YJ, Huang JL, Wu TJ, Cheng CC, Lin WS, Tuan TC, Chang SL, Lo LW, Hu YF, Chao TF, Chung FP, Tsai CF, Tsao HM, Chen SA.
    J Cardiovasc Electrophysiol; 2012 Jul 05; 23(7):750-6. PubMed ID: 22353378
    [Abstract] [Full Text] [Related]

  • 27. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.
    Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M.
    N Engl J Med; 1996 Dec 26; 335(26):1933-40. PubMed ID: 8960472
    [Abstract] [Full Text] [Related]

  • 28. Characteristics and relevance of clustering ventricular arrhythmias in defibrillator recipients.
    Stuber T, Eigenmann C, Delacrétaz E.
    Pacing Clin Electrophysiol; 2005 Jul 26; 28(7):702-7. PubMed ID: 16008807
    [Abstract] [Full Text] [Related]

  • 29. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS.
    Eur Heart J; 2000 Dec 26; 21(24):2071-8. PubMed ID: 11102258
    [Abstract] [Full Text] [Related]

  • 30. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.
    Ermis C, Seutter R, Zhu AX, Benditt LC, VanHeel L, Sakaguchi S, Lurie KG, Lu F, Benditt DG.
    J Am Coll Cardiol; 2005 Dec 20; 46(12):2258-63. PubMed ID: 16360055
    [Abstract] [Full Text] [Related]

  • 31. Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.
    Glikson M, Lipchenca I, Viskin S, Ballman KV, Trusty JM, Gurevitz OT, Luria DM, Eldar M, Hammill SC, Friedman PA.
    J Cardiovasc Electrophysiol; 2004 Jun 20; 15(6):658-64. PubMed ID: 15175060
    [Abstract] [Full Text] [Related]

  • 32. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F, Newman D, Greene M, Korley V, Mangat I, Dorian P.
    Circulation; 2004 Jul 13; 110(2):112-6. PubMed ID: 15238454
    [Abstract] [Full Text] [Related]

  • 33. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T, Paul TM, Eckardt L, Gerdes P, Kirchhof P, Böcker D, Breithardt G.
    Herz; 2005 Mar 13; 30(2):91-101. PubMed ID: 15875097
    [Abstract] [Full Text] [Related]

  • 34. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD, Burke MC, Hong TE, Kim S, Salem Y, Yong PG, Knight BP.
    J Cardiovasc Electrophysiol; 2006 May 13; 17(5):486-90. PubMed ID: 16684019
    [Abstract] [Full Text] [Related]

  • 35. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction.
    Zareba W, Moss AJ, Jackson Hall W, Wilber DJ, Ruskin JN, McNitt S, Brown M, Wang H, MADIT II Investigators.
    J Cardiovasc Electrophysiol; 2005 Dec 13; 16(12):1265-70. PubMed ID: 16403053
    [Abstract] [Full Text] [Related]

  • 36. Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients.
    Wilkoff BL, Hess M, Young J, Abraham WT.
    J Cardiovasc Electrophysiol; 2004 Sep 13; 15(9):1002-9. PubMed ID: 15363071
    [Abstract] [Full Text] [Related]

  • 37. Early and late survival after surgical revascularization for ischemic ventricular fibrillation/tachycardia.
    Ngaage DL, Cale AR, Cowen ME, Griffin S, Guvendik L.
    Ann Thorac Surg; 2008 Apr 13; 85(4):1278-81. PubMed ID: 18355509
    [Abstract] [Full Text] [Related]

  • 38. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
    Coats AJ.
    Int J Cardiol; 2002 Jan 13; 82(1):1-5. PubMed ID: 11786150
    [Abstract] [Full Text] [Related]

  • 39. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
    Rienstra M, Smit MD, Nieuwland W, Tan ES, Wiesfeld AC, Anthonio RL, Van den Berg MP, Van Veldhuisen DJ, Van Gelder IC.
    Am Heart J; 2007 Jan 13; 153(1):120-6. PubMed ID: 17174649
    [Abstract] [Full Text] [Related]

  • 40. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
    Lau EW, Griffith MJ, Pathmanathan RK, Ng GA, Clune MM, Cooper J, Marshall HJ, Forsey PR, Stafford PJ, Gray RG, Skehan JD, Garratt CJ.
    Europace; 2004 Jul 13; 6(4):257-66. PubMed ID: 15172648
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.